[
  {
    "text": "So the patent system has been a great driver\nof medical inventions.",
    "start": 5.1,
    "duration": 4.19
  },
  {
    "text": "We've seen some terrific discoveries and inventions\nin the medical space.",
    "start": 9.29,
    "duration": 5.07
  },
  {
    "text": "But as we've evolved in the system, I think\nwe're starting to see-- as a lawyer who's",
    "start": 14.36,
    "duration": 7.82
  },
  {
    "text": "practiced in this area, we're starting to\nsee a lot of strategies that are played by",
    "start": 22.18,
    "duration": 4.27
  },
  {
    "text": "pharmaceutical companies in order to maintain\ntheir monopolistic hold or their exclusivity",
    "start": 26.45,
    "duration": 5.12
  },
  {
    "text": "hold over a particular product.",
    "start": 31.57,
    "duration": 1.77
  },
  {
    "text": "And what they do is they ratchet up a number\nof patents around a particular product in",
    "start": 33.34,
    "duration": 5.129
  },
  {
    "text": "order to prevent competition from getting\nin.",
    "start": 38.469,
    "duration": 2.28
  },
  {
    "text": "And we all know that once you have competition,\nprices drive down.",
    "start": 40.749,
    "duration": 2.621
  },
  {
    "text": "There's a number of studies that show prices\ncan drop more than 50% if you get competition",
    "start": 43.37,
    "duration": 8.189
  },
  {
    "text": "in the marketplace sooner.",
    "start": 51.559,
    "duration": 1.121
  },
  {
    "text": "So the idea that companies want to do is to\nbasically prevent that competition from coming",
    "start": 52.68,
    "duration": 5.539
  },
  {
    "text": "in earlier.",
    "start": 58.219,
    "duration": 2.451
  },
  {
    "text": "And then the other argument of that is: are\nthey then really inventing new things?",
    "start": 60.67,
    "duration": 4.18
  },
  {
    "text": "Because what they do is they hold on to the\nmarketplace as long as they can on the existing",
    "start": 64.85,
    "duration": 4.16
  },
  {
    "text": "product.",
    "start": 69.01,
    "duration": 1.0
  },
  {
    "text": "They extend the franchise out by using patents,\nsometimes with the potential of holding the",
    "start": 70.01,
    "duration": 5.06
  },
  {
    "text": "market for 40 years unless litigated.",
    "start": 75.07,
    "duration": 2.399
  },
  {
    "text": "And we all know that litigation doesn't solve\nall the problems.",
    "start": 77.469,
    "duration": 3.671
  },
  {
    "text": "And we've seen that in a number of the top-selling\ndrugs in the United States.",
    "start": 81.14,
    "duration": 4.659
  },
  {
    "text": "We've done studies as an organization where\nwe have seen price hikes between 2012 and",
    "start": 85.799,
    "duration": 5.841
  },
  {
    "text": "2016 on the top 12 selling drugs in the United\nStates have 68%.",
    "start": 91.64,
    "duration": 5.479
  },
  {
    "text": "And we've seen in parallel to that the number\nof patents that have been stacked up on those",
    "start": 97.119,
    "duration": 4.75
  },
  {
    "text": "products, even after the product has been\napproved, even after the initial patent has",
    "start": 101.869,
    "duration": 5.71
  },
  {
    "text": "expired, which is a 20 year term.",
    "start": 107.579,
    "duration": 2.061
  },
  {
    "text": "And so they're just pushing it out further\nand further and further so that they can delay",
    "start": 109.64,
    "duration": 4.4
  },
  {
    "text": "the competition getting in.",
    "start": 114.04,
    "duration": 1.639
  },
  {
    "text": "And that all leads to market power and it\nall leads to the ability to increase prices",
    "start": 115.679,
    "duration": 5.601
  },
  {
    "text": "at will.",
    "start": 121.28,
    "duration": 6.289
  },
  {
    "text": "If you look at a pharmaceutical company, the\nscientists who work there, the people who",
    "start": 127.569,
    "duration": 4.641
  },
  {
    "text": "work on the development of drugs, their primary\npurpose is to help people, I believe.",
    "start": 132.21,
    "duration": 4.95
  },
  {
    "text": "I genuinely believe that.",
    "start": 137.16,
    "duration": 1.77
  },
  {
    "text": "I believe the conversations I've had with\npeople from that sector.",
    "start": 138.93,
    "duration": 4.15
  },
  {
    "text": "They believe that if they bring a new product\nto market and it saves someone's life or it",
    "start": 143.08,
    "duration": 4.26
  },
  {
    "text": "can actually make somebody healthy, they really\ndo believe that.",
    "start": 147.34,
    "duration": 5.78
  },
  {
    "text": "Unfortunately, there's a business side to\nit, as well.",
    "start": 153.12,
    "duration": 2.37
  },
  {
    "text": "And so what you have is for every scientist,\nyou have probably two lawyers who are watching",
    "start": 155.49,
    "duration": 4.24
  },
  {
    "text": "over them saying, “OK, how can we extract\na patent out of this and to make sure that",
    "start": 159.73,
    "duration": 4.76
  },
  {
    "text": "nobody else gets in there?”",
    "start": 164.49,
    "duration": 1.99
  },
  {
    "text": "And so what we have is then you have-- in\nparticularly the pharmaceutical market, there's",
    "start": 166.48,
    "duration": 3.51
  },
  {
    "text": "an argument that it's become overly financialized\nin terms of its investors who drive what companies",
    "start": 169.99,
    "duration": 6.83
  },
  {
    "text": "do, rather than maybe the initially intended\npurpose was to deliver health products and",
    "start": 176.82,
    "duration": 7.15
  },
  {
    "text": "to help make people not have to become ill\nand stay alive.",
    "start": 183.97,
    "duration": 5.31
  },
  {
    "text": "And I think some of that has got lost in the\nprocess as pharmaceutical companies now really",
    "start": 189.28,
    "duration": 7.8
  },
  {
    "text": "start to look at their bottom line and their\nshareholders and what the investors want rather",
    "start": 197.08,
    "duration": 4.05
  },
  {
    "text": "than what their original purpose was (to help\npeople become healthier).",
    "start": 201.13,
    "duration": 5.27
  },
  {
    "text": "And I think that the bargain of that has tilted\nmore towards the financial-ization of things",
    "start": 206.4,
    "duration": 5.93
  },
  {
    "text": "rather than thinking about health first.",
    "start": 212.33,
    "duration": 2.75
  },
  {
    "text": "I-MAK comprises lawyers and scientists who\nhave come from the private practice background.",
    "start": 215.08,
    "duration": 4.69
  },
  {
    "text": "We've all worked in industry.",
    "start": 219.77,
    "duration": 2.38
  },
  {
    "text": "I myself have been a solicitor in the United\nKingdom, working for the commercial side of",
    "start": 222.15,
    "duration": 5.72
  },
  {
    "text": "intellectual property for over 10 years.",
    "start": 227.87,
    "duration": 2.98
  },
  {
    "text": "And we've taken that knowledge to apply it\nin a public interest way, whereby we look",
    "start": 230.85,
    "duration": 5.66
  },
  {
    "text": "at, particularly in the pharmaceutical industry,\nhow do pharmaceutical corporations strategize",
    "start": 236.51,
    "duration": 7.04
  },
  {
    "text": "their patent filings in order to get the maximum\nprotection?",
    "start": 243.55,
    "duration": 4.98
  },
  {
    "text": "So what we do is, we look at a product, it\ncould even be still in development, and we'll",
    "start": 248.53,
    "duration": 5.91
  },
  {
    "text": "do what we call the due diligence and the\nanalysis of all their patent filings.",
    "start": 254.44,
    "duration": 4.98
  },
  {
    "text": "So for example, if it's a product that revolves\naround a small chemical compound, we'll identify",
    "start": 259.42,
    "duration": 6.32
  },
  {
    "text": "what that chemical structure is, and then\nwhat we'll do is we'll do patent searches.",
    "start": 265.74,
    "duration": 4.18
  },
  {
    "text": "There are various databases that you can use.",
    "start": 269.92,
    "duration": 2.22
  },
  {
    "text": "We put in keywords, we will use compound searches,\nand then we'll find out what it is that the",
    "start": 272.14,
    "duration": 6.65
  },
  {
    "text": "company has filed for.",
    "start": 278.79,
    "duration": 1.56
  },
  {
    "text": "And then we track how many other patents that\nthe company is adding on in the lifetime of",
    "start": 280.35,
    "duration": 4.55
  },
  {
    "text": "the product.",
    "start": 284.9,
    "duration": 1.0
  },
  {
    "text": "And that way, we build up a sense of what\nis their entire portfolio around that particular",
    "start": 285.9,
    "duration": 4.69
  },
  {
    "text": "product.",
    "start": 290.59,
    "duration": 1.02
  },
  {
    "text": "And that then gives us a sense of what their\nstrategy is, what potentially is the new version",
    "start": 291.61,
    "duration": 4.67
  },
  {
    "text": "of the product that they may be lining up.",
    "start": 296.28,
    "duration": 2.04
  },
  {
    "text": "So what they do is typically, products these\ndays in the pharmaceutical market, they're",
    "start": 298.32,
    "duration": 4.181
  },
  {
    "text": "on the market for five years and then they'll\nswitch it out to the next version of the product.",
    "start": 302.501,
    "duration": 3.159
  },
  {
    "text": "And these patents usually tell you what's\ncoming down the line.",
    "start": 305.66,
    "duration": 3.87
  },
  {
    "text": "And we use that essentially then to make decisions.",
    "start": 309.53,
    "duration": 3.38
  },
  {
    "text": "And often at the behest of organizations,\nsuch as Doctors Without Borders, who want",
    "start": 312.91,
    "duration": 3.9
  },
  {
    "text": "to get access to these products, but they\nsay “the patents are a barrier, the prices",
    "start": 316.81,
    "duration": 3.87
  },
  {
    "text": "are too high.”",
    "start": 320.68,
    "duration": 1.09
  },
  {
    "text": "And then we'll investigate the science behind\nthem as we're doing these analysis.",
    "start": 321.77,
    "duration": 4.08
  },
  {
    "text": "And what we realize is many times, the science\nbehind it is not new.",
    "start": 325.85,
    "duration": 4.53
  },
  {
    "text": "And then at that point, we decide whether\nwe want to challenge those patents in order",
    "start": 330.38,
    "duration": 3.62
  },
  {
    "text": "to remove the barriers so that competition\ncan get in earlier.",
    "start": 334.0,
    "duration": 3.47
  },
  {
    "text": "And by doing that, then we get generic competition\nin earlier if we're successful, and prices",
    "start": 337.47,
    "duration": 7.02
  },
  {
    "text": "drop significantly.",
    "start": 344.49,
    "duration": 1.35
  },
  {
    "text": "And we've achieved in various ways.",
    "start": 345.84,
    "duration": 1.66
  },
  {
    "text": "For example, in India, we've been very successful\nwith the HIV drug Kaletra, which is a product",
    "start": 347.5,
    "duration": 6.33
  },
  {
    "text": "owned by Abbott Laboratories and now Abbvie.",
    "start": 353.83,
    "duration": 2.84
  },
  {
    "text": "And we were able to challenge the key patents\non their drug such that Abbott eventually",
    "start": 356.67,
    "duration": 6.22
  },
  {
    "text": "withdrew all its patent applications, and\nIndian generic companies could continue to",
    "start": 362.89,
    "duration": 4.44
  },
  {
    "text": "supply this particular product at a much lower\nprice not only to Indian patients, but also",
    "start": 367.33,
    "duration": 6.13
  },
  {
    "text": "many patients around the world, and particularly\nin Africa.",
    "start": 373.46,
    "duration": 2.3
  },
  {
    "text": "And so we were to keep that market at a much\naccessible way for people living with HIV/AIDS.",
    "start": 375.76,
    "duration": 7.56
  },
  {
    "text": "And that, for us, has been one of the greatest\nsuccesses.",
    "start": 383.32,
    "duration": 3.32
  },
  {
    "text": "But more recently we've done it for the new\nHepatitis C drugs.",
    "start": 386.64,
    "duration": 3.67
  },
  {
    "text": "For example, just this year, we got a decision\nin the drug by Gilead called sofosbuvir.",
    "start": 390.31,
    "duration": 7.09
  },
  {
    "text": "We were able to win a case in China.",
    "start": 397.4,
    "duration": 2.42
  },
  {
    "text": "And China has 10 million people living with\nhepatitis C. And the fact that we won these",
    "start": 399.82,
    "duration": 4.24
  },
  {
    "text": "two cases in China now has the potential for\nother actors to come in and supply the Chinese",
    "start": 404.06,
    "duration": 6.53
  },
  {
    "text": "market, which could save conservatively, if\nyou were just to treat 15% of the people living",
    "start": 410.59,
    "duration": 6.66
  },
  {
    "text": "with hepatitis C in China, that would save\n$13 billion.",
    "start": 417.25,
    "duration": 3.61
  },
  {
    "text": "So overall, our impact of our work has the\npotential of saving $1 billion to the various",
    "start": 420.86,
    "duration": 5.23
  },
  {
    "text": "countries that then need to be able to get\naccess to these drugs.",
    "start": 426.09,
    "duration": 4.549
  }
]